RINGER LACTATE CEVA
RINGER LACTATE CEVA
Authorised
- Sodium chloride
- Sodium (S)-lactate solution
- Calcium chloride
- Potassium chloride
Product identification
Medicine name:
RINGER LACTATE CEVA
Active substance:
- Sodium chloride
- Sodium (S)-lactate solution
- Calcium chloride
- Potassium chloride
Target species:
-
All animal species
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Sodium chloride6.00/milligram(s)1.00millilitre(s)
-
Sodium (S)-lactate solution3.20/milligram(s)1.00millilitre(s)
-
Calcium chloride0.27/milligram(s)1.00millilitre(s)
-
Potassium chloride0.40/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for infusion
Withdrawal period by route of administration:
-
Intravenous use
-
All animal species
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QB05BB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Baxter
- Bieffe Medital S.A.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/0234645 6/2003
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 5/08/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 15/10/2025